Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Graph contrastive learning of subcellular-resolution spatial transcriptomics improves cell type annotation and reveals critical molecular pathways. | Brief Bioinform | 2024 | 39883515 | PubTator, text mining | PubMed |
| Synthesis and Characterization of Novel Co(III)/Ru(II) Heterobimetallic Complexes as Hypoxia-Activated Iron-Sequestering Anticancer Prodrugs. | Molecules | 2024 | 39770056 | PubTator, text mining | PubMed |
| Unraveling the protein kinase C/NDRG1 signaling network in breast cancer. | Cell Biosci | 2024 | 39736699 | PubTator, text mining | PubMed |
| [NDRG1 protein expression in breast cancer samples, relationship with lymph nodes metastasis]. | Arkh Patol | 2024 | 39686895 | PubTator, text mining | PubMed |
| The Role of NDRG1 Expression in Vasculogenic Mimicry of High-grade Gliomas. | J Cancer | 2024 | 39668822 | PubTator, text mining | PubMed |
| PARP enzyme de novo synthesis of protein-free poly(ADP-ribose). | Mol Cell | 2024 | 39536748 | PubTator, text mining | PubMed |
| Exploring epigenetic dynamics unveils a super-enhancer-mediated NDRG1-β-catenin axis in modulating gemcitabine resistance in pancreatic cancer. | Cancer Lett | 2024 | 39366545 | PubTator, text mining | PubMed |
| NDR1/FBXO11 promotes phosphorylation-mediated ubiquitination of β-catenin to suppress metastasis in prostate cancer. | Int J Biol Sci | 2024 | 39309441 | PubTator, text mining | PubMed |
| Metabolite of esculetin plays an important role in cytotoxic effects induced by chloroquine on porcine immature Sertoli cells. | Toxicol In Vitro | 2024 | 39278285 | PubTator, text mining | PubMed |
| Transcriptome analysis of the effect of HERV-K env gene knockout in ovarian cancer cell lines. | Genes Genomics | 2024 | 39271536 | PubTator, text mining | PubMed |
| Variants in tubule epithelial regulatory elements mediate most heritable differences in human kidney function. | Nat Genet | 2024 | 39256582 | PubTator, text mining | PubMed |
| Identification and Characterization of Novel Founder Mutations in NDRG1: Refining the Genetic Landscape of Charcot-Marie-Tooth Disease Type 4D in Bulgaria. | Int J Mol Sci | 2024 | 39201732 | PubTator, text mining | PubMed |
| Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma. | Biomolecules | 2024 | 39199357 | PubTator, text mining | PubMed |
| Elevated expression of N-myc downstream regulated gene 1 protein in glioblastomas reflects tumor angiogenesis and poor patient prognosis. | Neuropathology | 2024 | 39105501 | PubTator, text mining | PubMed |
| The role of metabolic memory in diabetic kidney disease: identification of key genes and therapeutic targets. | Front Pharmacol | 2024 | 39092227 | PubTator, text mining | PubMed |
| Monitoring nucleolar-nucleoplasmic protein shuttling in living cells by high-content microscopy and automated image analysis. | Nucleic Acids Res | 2024 | 39036969 | PubTator, text mining | PubMed |
| Comprehensive analysis of hub genes associated with cisplatin-resistance in ovarian cancer and screening of therapeutic drugs through bioinformatics and experimental validation. | J Ovarian Res | 2024 | 38987777 | PubTator, text mining | PubMed |
| NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation. | Front Pharmacol | 2024 | 38983911 | PubTator, text mining | PubMed |
| NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer. | Mol Cancer | 2024 | 38970106 | PubTator, text mining | PubMed |
| Merkel Cell Polyomavirus targets SET/PP2A complex to promote cellular proliferation and migration. | Virology | 2024 | 38917692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=7